Font Size: a A A
Keyword [EGFR-TKI]
Result: 1 - 20 | Page: 1 of 10
1. Predictors Of EGFR-TKI Therapy In Chinese NSCLC And Mechanisms Of Downstream Signal Pathway In EGFR Family
2. The Efficacy Prediction Of Tyrosine Kinase Inhibitor For Treatment Of Advanced Non-small Cell Lung Cancer And The Related Basic Research
3. Combined Epidermal Growth Factor Receptor Targeting With The Tyrosine Kinase Inhibitor And The Monoclonal Antibody In No-Small Cell Lung Cancer
4. The Study Of Curative Effect Prediction And Monitoring Factors In Treatment On Advanced Non-Small Cell Lung Cancer Using Egfr-tki
5. Methylation Of MiR-200c Promoter Region Is Associated With Resistance To EGFR-TKI In Lung Cancer Cells
6. Design And Synthesis Of A Novel Anti - Tumor Drug EGFR - TKI Target For Molecular Targets
7. Effect Of EGFR-TKI On Axonal Regeneration Of Rabbit Facial Nerve In Regeneration Chamber: An Experimental Study
8. The Clinical Efficacy And Tolerability Of EGFR-TKI In Locally Advanced Or Metastatic NSCLC Patients
9. The Effects Of Combined Administration Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors And Cytotoxic Drugs In Different Tumor Cell Lines
10. Comparing ARMS And Sequencing In Detecting EGFR Mutation And The Prediction Of EGFR-TKI Response In NSCLCs
11. Observation On The Therapeutic Effect Of Antipruritic Skin Cream On EGFR - TKI - Related Rash
12. An Exploratory Study On The Changes Of Serum Polypeptide And Its Clinical Significance In The Treatment Of EGFR - TKI In Patients With Advanced NSCLC
13. Analysis Of Mutation Of Plasma Free DNA EGFR Gene And Its Correlation With EGFR - TKI Effect By DdPCR Method
14. Research On Effection And Mechanism Of Radiosensitivity Of Non-small Cell Lung Cancer A549 & H1975 Following Gefitinib Treatment
15. Serum CEA Level Is Associated With Efficacy And Prognosis Of EGFR-TKI Treatment In Non-small Cell Lung Cancer
16. The Role Of Integrin β1 Up-regulated In Resistance Of Non-small Cell Lung Cancer To EGFR TKI
17. Signaling Pathway Differences Between EGFR TKI Sensitive And Resistant NSCLC Cells And Preliminary Study Of MTOR Targeted Treatment
18. Exploration Of Expression And Significance Of C-Met And Soluble Met In Lung Cancer
19. The Modulation And Related Mechanism Of PD-L1 Expression In Non-small-cell Lung Cancer
20. The Pharmacodynamic Experiment And Retrospective Study Of Pemetrexed Combined With EGFR-TKI In Lung Squamous Cell Cancer
  <<First  <Prev  Next>  Last>>  Jump to